Transcriptomic analysis of neural stem and progenitor cells in comparison with glioblastoma stem cells
Introduction. There is currently no effective therapy for the treatment of glioblastoma. This is partly explained by the high degree of intra- and intertumor heterogeneity of GB, the source of which is believed to be glioblastoma stem cells (GSC). The question of the origin of GSC, which is importan...
Saved in:
| Main Authors: | V. E. Shevchenko, N. E. Arnotskaya, T. I. Kushnir, A. S. Bryukhovetskiy |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2023-12-01
|
| Series: | Успехи молекулярной онкологии |
| Subjects: | |
| Online Access: | https://umo.abvpress.ru/jour/article/view/615 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Stem cell therapies and glioma stem cells in glioblastoma: a systematic review of current challenges and research directions
by: Olivier Uwishema, et al.
Published: (2025-08-01) -
Ferroptosis determinants - potential therapeutic targets glioblastoma stem cells
by: V. E. Shevchenko, et al.
Published: (2022-10-01) -
Cytotoxic effects of Methoxy-substituted Chalcones on glioblastoma stem cells: Computational target prediction and therapeutic insights
by: Eduardo A. Veliz, et al.
Published: (2025-03-01) -
MET inhibition overcomes radiation resistance of glioblastoma stem‐like cells
by: Francesca De Bacco, et al.
Published: (2016-04-01) -
Study of interaction between extracellular matrix proteins and receptors of CD133+ stem cells and CD133– differentiated glioma cells
by: V. E. Shevchenko, et al.
Published: (2019-04-01)